Clinical Trial: Rifaximin Versus Low <scp>FODMAP</scp> Diet in Irritable Bowel Syndrome

Authors

Institutions

Publication Details

Journal
Alimentary Pharmacology & Therapeutics
Published
2025-10-16
DOI
https://doi.org/10.1111/apt.70420
Citations
4
Primary Topic
Gastrointestinal motility and disorders
Type
article
Field-Weighted Citation Impact
7.24
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Clinical Trial: Rifaximin Versus Low FODMAP Diet in Irritable Bowel Syndrome

Kee Huat Chuah, Xin Hui Khoo, Qing Yuan Loo, Ai Kah Ng et al.
4 citations
Alimentary Pharmacology & Therapeutics
Gastrointestinal motility and disorders
7.24
article

Clinical Trial: Rifaximin Versus Low FODMAP Diet in Irritable Bowel Syndrome

Kee Huat Chuah, Xin Hui Khoo, Qing Yuan Loo, Ai Kah Ng, Kum Thong Wong, Audrey Joe Chii Loh, Hazreen Abdul Majid, Wah Loong Chan, Sanjiv Mahadeva, Ven Natarajan, Jing Yi Leong, Sarala Panirsheeluam
article en
4 citations

Abstract

No abstract available for this paper.
Alimentary Pharmacology & TherapeuticsVol. 63(2)
University Malaya Medical Centre (MY), University of Malaya (MY), Bournemouth University (GB)
Openalex Percentile: Top 3%
Gastrointestinal motility and disorders
7.24
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.